Lignocellulosic biomass is a flexible renewable useful resource for fuels, buildings, crafts, and biomaterials. Strategies of molecularly designing lignocellulose for industrial software has been developed by the discoveries of novel genes after the screenings of varied mutants and remodeled traces of Arabidopsis whose cell partitions might be modified in the inflorescence stem, a mannequin woody tissue. The mechanical properties are used as a quantitative index for the chemorehological conduct of the genetically modified cell wall in the tissue.
This parameter could be measured with tensile or bending checks of tissue explants, the vibration evaluation of tissue conduct or utilizing atomic power microscopy to probe the tissue floor. Here, we describe in element the process to find out the stiffness of methanol-fixed, rehydrated and pronase-treated inflorescence explants with a tensile testing machine primarily based on classical strategies for the dedication of cell wall extensibility.
Extracellular matrix (ECM)-based tissue engineering scaffolds have a necessary position in selling tissue regeneration. Nerve tissue engineering goals at facilitating the restore of everlasting injury to the peripheral and central nervous methods, that are tough to heal. For this function, a range of biomaterials are being developed consisting of quite a few artificial and/or pure polymers to offer axonal reinnervation and to direct the development of axons. Here, we current a novel protocol that permits to manufacture a three-d (3D) decellularized scaffold derived from the bovine spinal twine (BSC) ECM (3D-dCBS) for neural tissue engineering purposes.
In this protocol, a viscous ECM-derived gel from BSC is ready, molded, and chemically crosslinked with EDC/NHS (3D-CBS) earlier than decellularization course of. Decellularization of 3D-CBS is carried out with 1% SDS to realize 3D-dCBS. As in contrast with different out there strategies, our protocol is a novel decellularization technique that preserves a extra important half of the ECM. We imagine that the talked about protocol has the potential to supply a bioengineered scaffold from spinal twine tissue with desired geometry for regenerative drugs purposes associated to neural tissue engineering.
The Fabrication of Poly( Σ-caprolactone)-Poly(ethylene oxide) Sandwich Type Nanofibers Containing Sericin-Capped Silver Nanoparticles as an Antibacterial Wound Dressing
In this examine, antibacterial, artificial poly(Σ-caprolactone)-poly(ethylene oxide) (PCL-PEO) multilayer nanofibers had been produced by an electrospinning technique. The materials was synthesized in Three layers. The upper-lower protecting layers had been produced by PCL nanofibers and the intermediate layer was produced from PEO nanofiber containing sericin-capped silver nanoparticles (S-AgNPs). The electrospinning circumstances in which nano-sized, clean, bead-free fibers had been obtained was decided to be an utilized voltage of 20 kV, a circulate price of 8 μL/min and a distance between the collector and the needle tip of 22 cm for the PCL layer (dissolved at a 12% g/mL focus in a chloroform:methanol (3:2) solvent combination) layer.
For the S-AgNPs doped PEO layer (dissolved at a 3.5% g/mL focus in water), the corresponding circumstances had been decided to be 20 kV, 15 μL/min and 20 cm.To characterize the three-layer materials that consisted of PCL and S-AgNPs doped PEO layers, FTIR and SEM analyses had been carried out, and the water retention capability, in situ degradability and antibacterial exercise of the materials was investigated.
According to SEM evaluation, the fibers obtained had been discovered to be nano-sized, clean and bead-free and the common measurement of the nanofibers forming the PCL layer was 687 nm whereas the common measurement of the fibers forming the PEO layer was 98 nm. Antibacterial exercise checks had been carried out utilizing gram-positive (Staphylococcus aureus ATCC 6538) and gram-negative (Escherichia coli ATCC 25922) micro organism and the ensuing biomaterial was discovered to have antimicrobial impact on each gram-negative and gram-positive micro organism. It was decided that the 3-layer materials obtained in this examine can be utilized as a wound dressing.
Peptide-Chitosan Engineered Scaffolds for Biomedical Applications
Peptides are signaling epitopes that management many important organic occasions. Increased specificity, artificial feasibility with concomitant lack of toxicity, and immunogenicity make this rising class of biomolecules appropriate for totally different purposes together with therapeutics, diagnostics, and biomedical engineering. Further, chitosan, a naturally occurring linear polymer composed of d-glucosamine and N-acetyl-d-glucosamine items, possesses anti-microbial, muco-adhesive, and hemostatic properties together with wonderful biocompatibility.
As a end result, chitosan finds software in drug/gene supply, tissue engineering, and bioimaging. Despite these purposes, chitosan demonstrates restricted cell adhesion and lacks biosignaling. Therefore, peptide-chitosan hybrids have emerged as a brand new class of biomaterial with improved biosignaling properties and cell adhesion properties. As a end result, current research embody elevated software of peptide-chitosan hybrids as composites or conjugates in drug supply, cell remedy, and tissue engineering and as anti-microbial materials. This evaluate discusses the current investigations involving chitosan-peptide supplies and uncovers varied facets of these attention-grabbing hybrid supplies for biomedical purposes.
Tetanus Toxoid scFv Antibody |
abx137499-100tests |
Abbexa |
100 tests |
EUR 225 |
FMC63 scFv, His Tag (SPR verified) |
CD9-M52Hb |
ACROBIOSYSTEMS |
100ug |
EUR 1487.3 |
|
Description: FMC63 scFv, His Tag (CD9-M52Hb) is expressed from human 293 cells (HEK293). It mimics the scFv presented on CAR-T cells which target CD19. |
Anti-TNFRSF8 (clone Ki4) scFv-MAP ADC |
ADC-W-354 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (clone Ki4) conjugated via a linker to a MAP |
Recombinant (E.Coli) Anti-Tetanus Toxoid scFv IgG |
RP-343 |
Alpha Diagnostics |
10 ug |
EUR 343.2 |
Anti-ROR1 (clone R11) scFv-Fc-Sec ADC |
ADC-W-434 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ROR1 scFv-Fc (clone R11) conjugated via a engineered selenocysteine (Sec) residue linker to a drug |
SARS-CoV-2 Nucleocapsid Protein scFv Antibody |
abx229488-100g |
Abbexa |
100 µg |
EUR 1725 |
Anti-COVID-19 Nucleocapsid Protein scFv Antibody |
E38A9964 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Biotinylated FMC63 scFv, Fc,Avitag™ (MALS verified) |
CD9-BV4324b |
ACROBIOSYSTEMS |
25ug |
EUR 1294.7 |
|
Description: Biotinylated FMC63 scFv, Fc, Avitag is a chimeric monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. |
Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 |
CABT-Z294M |
Creative Diagnostics |
25 tests; 250 tests |
Ask for price |
|
Description: Mouse |
E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody |
DL99719A-100ul |
DL Develop |
100 ul |
EUR 299 |
|
Description: Nucleoprotein; Nucleocapsid protein; NC; Protein N |
E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody |
DL99719A-50ul |
DL Develop |
50 ul |
EUR 210 |
|
Description: Nucleoprotein; Nucleocapsid protein; NC; Protein N |
SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV) |
E-AB-V1012-1mg |
Elabscience Biotech |
1mg |
EUR 9200 |
|
Description: Unconjugated |
SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV) |
E-AB-V1012-each |
Elabscience Biotech |
each |
Ask for price |
|
Description: Unconjugated |
Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [PE] |
CABT-Z293M |
Creative Diagnostics |
25 tests |
EUR 840 |
|
Description: Mouse |
Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [FITC] |
CABT-Z296M |
Creative Diagnostics |
25 tests; 200 tests |
Ask for price |
|
Description: Mouse |
Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [Biotin] |
CABT-Z295M |
Creative Diagnostics |
25 tests; 200 tests |
Ask for price |
|
Description: Mouse |
Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ) |
78600 |
BPS Bioscience |
50 µl |
EUR 1150 |
Description: The anti-CD19 CAR lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express the ScFv portion of anti-CD19 (clone FMC63) linked to 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge, 4-1BB, and CD3ζ signaling domains. |
AS Control |
A26 |
DataApex |
- |
EUR 330 |
Description: SW module for AS control |
GC Control |
A23 |
DataApex |
- |
EUR 600 |
Description: SW module for GC control |
LC Control |
A24 |
DataApex |
- |
EUR 600 |
Description: SW module for HPLC/CE control (pump, det, etc.) |
Rat neurofascin (Nfasc)-control Control/blocking peptide |
AB-23249-CP |
Alpha Diagnostics |
100ug |
EUR 196.8 |
Rat IgG-PE conjugate (isotype control) (Isotype control) |
20005-PE |
Alpha Diagnostics |
25 tests |
EUR 242.4 |
Dengue Control |
ant-543 |
ProSpec Tany |
100µg |
EUR 165 |
Description: Mouse Anti-Dengue Control for Lateral Flow Test |
Rat IgG-HRP conjugate (isotype control) (Isotype control) |
20005-HP |
Alpha Diagnostics |
100 ug |
EUR 196.8 |
Rat IgG-FITC conjugate (isotype control) (Isotype control) |
20005-F |
Alpha Diagnostics |
100 ug |
EUR 196.8 |
Quality Control |
abx098966-1vial |
Abbexa |
1 vial |
EUR 360 |
|
Rat IgG-Biotin conjugate (isotype control) (Isotype control) |
20005-B |
Alpha Diagnostics |
100 ug |
EUR 196.8 |
PIPET CONTROLLER CONTROL BOARD |
357484 |
CORNING |
1/pk |
EUR 104.4 |
Description: Falcon Liquid Handling Equipment; Falcon Pipet Controllers and Accessories |
Goat IgG (-ve control for flow cytometry) (isotype control) |
20011-100 |
Alpha Diagnostics |
100 test |
EUR 123.6 |
Control for Tyrosinase, 4 cases (1.5mm)HumanskinSkinIHC control |
TYROSIN081 |
Pantomics |
1.5mm |
EUR 50 |
Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv) |
BSFV-072-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy. |
Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv) |
BSFV-072-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy. |
Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) |
BSFV-162-100ug |
Creative Biolabs |
100μg |
EUR 4552.8 |
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy. |
Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) |
BSFV-162-50ug |
Creative Biolabs |
50μg |
EUR 2587.2 |
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy. |
Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-c001-100ug |
Creative Biolabs |
100μg |
EUR 4552.8 |
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy. |
Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-c001-50ug |
Creative Biolabs |
50μg |
EUR 2587.2 |
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy. |
Control siRNA Vector (pGB-control) |
9500C-20 |
Biovision |
each |
EUR 405.6 |
Anti-Amyloid Beta Reference Antibody (CSIRO anti-amyloid Beta scFv) |
E24CHA691 |
EnoGene |
100 μg |
EUR 225 |
Description: Available in various conjugation types. |
Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-020-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy. |
Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-020-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy. |
Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-030-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy. |
Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-030-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy. |
Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-041-100ug |
Creative Biolabs |
100μg |
EUR 4552.8 |
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy. |
Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-041-50ug |
Creative Biolabs |
50μg |
EUR 2587.2 |
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy. |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
BSFV-046-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
BSFV-046-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-066-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy. |
Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-066-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy. |
Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-077-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-077-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-079-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy. |
Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv) |
BSFV-079-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy. |
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv) |
BSFV-102-100ug |
Creative Biolabs |
100μg |
EUR 4272 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy. |
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv) |
BSFV-102-50ug |
Creative Biolabs |
50μg |
EUR 2446.8 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy. |
OOSA10387-100T - IgM NEGATIVE CONTROL Negative/Isotype Control |
OOSA10387-100T |
Aviva Systems Biology |
100Tests |
EUR 309 |
|
OOSA10342-100UG - IgG1 NEGATIVE CONTROL Negative/Isotype Control |
OOSA10342-100UG |
Aviva Systems Biology |
0.1mg |
EUR 219 |
|
OOSA10349-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control |
OOSA10349-100T |
Aviva Systems Biology |
100Tests |
EUR 299 |
|
OOSA10380-100T - IgG2b NEGATIVE CONTROL Negative/Isotype Control |
OOSA10380-100T |
Aviva Systems Biology |
100Tests |
EUR 309 |
|
OOSA10389-100T - IgG1 NEGATIVE CONTROL Negative/Isotype Control |
OOSA10389-100T |
Aviva Systems Biology |
100Tests |
EUR 309 |
|
OOSA10397-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control |
OOSA10397-100T |
Aviva Systems Biology |
100Tests |
EUR 309 |
|
Anti-CD22 CAR Lentivirus (Clone m971 ScFv-CD8-4-1BB-CD3ζ) |
78608 |
BPS Bioscience |
50 µl |
EUR 1095 |
Description: The anti-CD22 CAR lentiviruses are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv (single-chain variable fragment) of anti-CD22 (clone m971) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (below). |
Control for Mammaglobin, 4 cases (1.5mm)HumanBreastBreastIHC control |
MAMA-G081 |
Pantomics |
1.5mm |
EUR 50 |
Rat Control IgG |
AC034 |
Abclonal |
100 ul |
EUR 159.6 |
β-Gal Control |
LV007 |
ABM |
4 x 500 ul |
EUR 195 |
Anti-BCMA CAR Lentivirus (Clone C11D5.3 ScFv-CD8-4-1BB-CD3ζ) |
78655 |
BPS Bioscience |
50 µl |
EUR 1095 |
Description: The anti-BCMA CAR lentiviruses are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv (single-chain variable fragment) of anti-BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). The lentiviruses also transduce a puromycin selection gene. |
Goat IgG control |
31R-AG001 |
Fitzgerald |
1 mg |
EUR 104 |
|
Description: Goat Immunoglobulins Goat IgG control |
Goat IgG Control |
GT15900 |
Neuromics |
1 mg |
EUR 199.2 |
Rat IgG1 Control |
mabg1-ctlrt |
InvivoGen FR |
100 µg |
Ask for price |
MG-BSA Control |
STA-306 |
Cell Biolabs |
100 µg |
EUR 386.4 |
Description: - Methylglyoxal-BSA (MG-BSA) may be used as a positive control. 100 µg at 1 mg/mL in PBS.
- Provided at 1 mg/mL
|
Control for GCDFP-15, 4 cases (1.5mm)HumanBreastBreastIHC control |
GCDFP081 |
Pantomics |
1.5mm |
EUR 50 |
Mouse IgG Control |
10R-I169A |
Fitzgerald |
250 ug |
EUR 104 |
|
Description: Mouse Immunoglobulins Mouse IgG Control |
human IgM control |
E4A11C04 |
EnoGene |
50ug |
EUR 255 |
Description: Available in various conjugation types. |
human IgE control |
E4A11C05 |
EnoGene |
50ug |
EUR 255 |
Description: Available in various conjugation types. |
Mouse Control IgG |
AC011 |
Abclonal |
100 ul |
EUR 143 |
|
Description: None |
Mouse IgM Control |
ICIGMF-100 |
ImmunoStep |
100 µg |
EUR 239.4 |
Mouse IgM Control |
ICIGMPU-100 |
ImmunoStep |
100 µg |
EUR 239.4 |
Rat IgG2a Control |
mabg2a-ctlrt |
InvivoGen FR |
100 µg |
EUR 101.85 |
Rat IgG2a Control |
mabg2a-ctlrt-05 |
InvivoGen FR |
5 x 100 µg |
EUR 163.8 |
Rat IgG2b Control |
mabg2b-ctlrt |
InvivoGen FR |
100 µg |
Ask for price |
CML-BSA Control |
STA-314 |
Cell Biolabs |
100 µg |
EUR 386.4 |
Description: - CML-BSA may be used as a positive control. 100 µg.
- Provided at 1 mg/mL in 1X PBS
|
human IgM control |
E4A11D04 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
human IgE control |
E4A11D05 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
OOSA10361-1ML - Rat IgG2a NEGATIVE CONTROL Negative/Isotype Control |
OOSA10361-1ML |
Aviva Systems Biology |
1ml |
EUR 169 |
|
Control for MSH2, 4 cases (1.5mm)HumanDigestive systemColonIHC control |
MSH2081 |
Pantomics |
1.5mm |
EUR 50 |
Control for Olig2, 4 cases (1.5mm)HumanNervous systemBrainIHC control |
OLIG2081 |
Pantomics |
1.5mm |
EUR 50 |
Rabbit IgG Control |
31R-AR001 |
Fitzgerald |
500 ug |
EUR 94 |
|
Description: Purified Normal Rabbit IgG |
human IgG1 control |
E4A11C03 |
EnoGene |
50ug |
EUR 255 |
Description: Available in various conjugation types. |
Rabbit Control IgG |
AC005 |
Abclonal |
100 ul |
EUR 143 |
|
Description: A synthetic peptide corresponding to Actin (plant specific). |
Mouse IgG1 Control |
ICIGG1AC750-50 |
ImmunoStep |
50 µg |
EUR 855.6 |
Mouse IgG1 Control |
ICIGG1PU-100 |
ImmunoStep |
100 µg |
EUR 239.4 |
Mouse IgG3 Control |
ICIGG3CFB-100 |
ImmunoStep |
100 µg |
EUR 465.6 |
Human IgA2 Control |
maba2-ctrl |
InvivoGen FR |
100 µg |
EUR 101.85 |
Human IgA2 Control |
maba2-ctrl-05 |
InvivoGen FR |
5 x 100 µg |
EUR 163.8 |
Mouse Control IgG1 |
mabg1-ctrlm |
InvivoGen FR |
100 µg |
EUR 99.75 |
Mouse Control IgG1 |
mabg1-ctrlm-05 |
InvivoGen FR |
5 x 100 µg |
EUR 163.8 |
Due to the lack of vascular distribution and the sluggish metabolism, cartilage tissue can’t restore itself, which stays an enormous problem for cartilage regeneration. Tissue engineering utilizing stem cells seems to be a promising technique for cartilage restore. Tissue engineers demonstrated that mechanical stimulation can improve the high quality of engineered cartilage, making it extra much like pure cartilage in construction and performance. In this evaluate, we summarize current research on the position of mechanical stimuli in chondrogenesis, specializing in the purposes of extrinsic mechanical loading and the research on mechanical properties of biomaterials in cartilage tissue engineering. This evaluate will present contemporary insights into the potential use of mechanical stimuli for scientific use.